Manitex Capital Inc. Can’t Burn Your Long Portfolio. Has Another Strong Session

 Manitex Capital Inc. Can't Burn Your Long Portfolio. Has Another Strong Session

The stock of Manitex Capital Inc. (CVE:MNX) is a huge mover today! About 36,000 shares traded hands or 1957.14% up from the average. Manitex Capital Inc. (CVE:MNX) has risen 6.00% since October 5, 2016 and is uptrending. It has outperformed by 4.91% the S&P500.
The move comes after 5 months positive chart setup for the $3.68 million company. It was reported on Nov, 4 by Barchart.com. We have $0.93 PT which if reached, will make CVE:MNX worth $6.11M more.

More recent Manitex Capital Inc. (CVE:MNX) news were published by: Marketwatch.com which released: “Manitex Capital Inc. acquires convertible debentures of Cold Water Fisheries …” on September 22, 2016. Also Marketwatch.com published the news titled: “Manitex Capital Inc. announces that Valeo Pharma Inc. sold its dermatology …” on August 25, 2014. Marketwired.com‘s news article titled: “Manitex International, Inc. Will Participate in RBC Capital Markets’ Global …” with publication date: August 25, 2016 was also an interesting one.

Manitex Capital Inc. is a Canada-based firm that specializes in acquiring interests in companies and participates in increasing shareholder value in these businesses. The company has a market cap of $3.68 million. The Firm operates through three divisions: diversified investments , biotechnology (biotech) and a pharmaceutical business (pharma). It currently has negative earnings. The investment segment holds interests in companies in the life science industry and also invests in marketable securities.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment